SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery

Conditions: Breast Cancer Interventions: Drug: SRG-514 Sponsors: SURGE Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials